Press release
Multiplexed Diagnostics Market: Multiplexed Diagnostics Manufacturers should Focus on Developing Automated Systems, Recommends TMR
Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1719
Multiplexed diagnostics techniques include very high density multiplexed assays, high density multiplexed assays, medium density multiplexed assays, low density multiplexed assays and next-generation sequencing. All the technologies used in multiplexing are based on the principle of screening of multiple analytes in single cycle of the assay. Very high density multiplexed assays include oligonucleotide arrays and phage display. High density multiplexed assays include bacterial artificial chromosome arrays and protein arrays. Medium density multiplexed assays include bead-based arrays, antibody assays, reverse assays and mass spectroscopy. Low density multiplexed assays include qPCR bead-based assays and microplate assays.
Currently, medium density multiplexed assay market leads the overall multiplexed diagnostics market and is followed by low density multiplexed diagnostics assays. Bead-based arrays and antibody arrays is the most preferred multiplexed technique. Medium density arrays market is dominating the industry due to its multiple applications in other technologies used in the multiplexed diagnostics. For instance, bead-based assays used in combination with immunoassays and oligonucleotides in combination with protein assays. The cost of medium density multiplexed assays is lesser as compared to very high density and high density multiplexed assays thus resulting in added affordability and thereby growth in demand in emerging economies.
The global multiplexed diagnostics market is highly consolidated in nature. Bigger market players lead this market with their proprietary products and robust development strategies. Established players in the market follow the trend of large scale union and collaborative activities such as supply agreements, acquisitions and partnerships to expand their market share. Intensive competitive rivalry exists in the market as a result of price competition due to the presence of limited market players in the industry.
Geographically, North America is leading the global multiplexed diagnostics market. Highly developed healthcare infrastructure, developed technology and high rates of adoption are some of the major factors that are driving the growth of multiplexed diagnostics market in the North America. Asia-Pacific is the lucrative market for multiplexed diagnostics market owing to rapidly growing medical industry in the region.
Browse Research Report: http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html
In addition, Asia-Pacific covers more than 50% of the global population and demonstrates the highest rates of morbidity of infectious diseases and cardiac diseases in this region. Japan is currently the most dominant market in the Asia-Pacific region and is followed by China and India. Government initiatives to create awareness about the available diagnostic procedures and research activities to boost the biotechnology industry in the respective countries will further augment the growth of multiplexed diagnostics market in emerging economies.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiplexed Diagnostics Market: Multiplexed Diagnostics Manufacturers should Focus on Developing Automated Systems, Recommends TMR here
News-ID: 400005 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Multiplexed
Multiplexed Diagnostics Market Forecasted to Reach 2019-2027
Transparency Market Research (TMR) has published a new report titled, 'Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global multiplexed diagnostics market was valued at around US$ 8.7 Bn in 2018 and is projected to grow at a CAGR of 17.9% from 2019 to 2027.
Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1719
Overview
•Diagnostic assays are tests used to assess target analytes, quantitatively or qualitatively,…
Valuable Report on Multiplexed Diagnostics Market, 2021-2026
(Portland, United States): A new market research report by Big Market Research on Multiplexed Diagnostics Market reveals that the market is estimated to grow with a substantial growth rate from 2021-2026. This report is a valuable document for major players and the new entrants to scrutinize the market in detail. The insights offered in the report will help the market players to formulate their business strategies and achieve a vital…
Multiplexed Diagnostics Market to Witness Revolutionary Growth
Transparency Market Research (TMR) has published a new report titled, ‘Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global multiplexed diagnostics market was valued at around US$ 8.7 Bn in 2018 and is projected to grow at a CAGR of 17.9% from 2019 to 2027.
Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1719
Overview
Diagnostic assays are tests used to assess target analytes, quantitatively or qualitatively, in biochemical substances, cells of an organism, or an organic…
RFmondial demonstrates multiplexed DRM at IBC 2019
Hannover, 12.09.2019 – RFmondial demonstrates its advanced multiplexed DRM modulation for the FM band, that allows broadcasters to transmit multiple DRM channels on one physical transmitter.
The newest member of RFmondial’s successful LV-series of DRM modulators and exciters allows the parallel generation and transmission of up to six pure digital DRM channels, or in combined analog and digital „Simulcast” mode, one traditional analog FM channel and up to four DRM channels.
„The…
Multiplexed Diagnostics Market 2017 Specifications and Applications Analysis
Summary:
Latest Research Report “Global Multiplexed Diagnostics Market” Added by Orbis Research which covers Market Overview, Product Specification, Profit, Production, Capacity Utilization, Supply, Manufacturing Process & Cost Structure for Different Regions.
2017 Market Research Report on Multiplexed Diagnostics Industry was a professional and depth research report on Multiplexed Diagnostics industry that you would know the world's major regional market conditions of Multiplexed Diagnostics industry, the main region including North American, Europe and…
Multiplexed Diagnostics Market 2024 - Analysis and Trends
Global Multiplexed Diagnostics Market: Snapshot
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify…
